How to Switch from Zepbound to Foundayo (Orforglipron)
Switch from Zepbound (tirzepatide) to Foundayo — different drug classes, what changes, and why Lilly designed this exact transition path.
Why Switch from Zepbound to Foundayo?
This is the switch Lilly wants you to make. Their commercial strategy positions Zepbound for aggressive weight loss and Foundayo for long-term maintenance. Here's why it makes sense:
- Zepbound is the heavy hitter — up to 22.5% weight loss at max dose (15mg). But once you've hit your goal, you may not need that level of pharmacological firepower.
- Cost savings — Zepbound lists at $1,059/month vs Foundayo at $149-349/month (dose-dependent)
- Oral convenience — Switch from weekly injections to a daily pill
- Different mechanism may reduce tolerance — Switching from dual GIP/GLP-1 to GLP-1-only changes the receptor stimulation pattern
- No food restrictions — Foundayo can be taken any time with food
Important distinction: Zepbound is a dual GIP/GLP-1 agonist; Foundayo is a GLP-1-only partial agonist. You're losing the GIP component, which contributed to Zepbound's superior efficacy. This trade-off only makes sense if you're in maintenance mode.
Dose Equivalence: Zepbound to Foundayo
Zepbound and Foundayo work through different mechanisms, so there's no direct dose equivalence. The transition is based on clinical trial data from the ATTAIN program:
| Zepbound Dose | Foundayo Target | Notes |
|---|---|---|
| 2.5mg | 0.8mg start | Both are starter doses |
| 5mg | Titrate to 5.5-9mg | ~8-12 weeks |
| 7.5mg | Titrate to 9-14.5mg | ~12-16 weeks |
| 10mg | Titrate to 14.5-17.2mg | ~16-20 weeks |
| 12.5-15mg | 17.2mg (max) | Max Foundayo; may not match Zepbound efficacy |
Be realistic: If you're on Zepbound 15mg and still actively losing weight, Foundayo 17.2mg will not provide equivalent weight loss. This switch works best when you've reached your goal weight and are switching to maintenance.
Understanding the Mechanism Change
This switch involves a bigger pharmacological change than switching between semaglutide products:
Zepbound (tirzepatide): Dual GIP + GLP-1 receptor agonist. Stimulates both incretin pathways for maximum metabolic effect.
Foundayo (orforglipron): GLP-1-only partial agonist. Stimulates GLP-1 receptors at a lower intensity, with no GIP activity.
What this means for you:
- The GIP component contributed significantly to Zepbound's appetite suppression — you may notice slightly increased hunger
- Partial agonism means less receptor stimulation overall — generally fewer side effects but also less raw efficacy
- Your body may take 4-6 weeks to fully adjust to the different pharmacological profile
Side Effects Comparison
Moving from Zepbound to Foundayo generally means milder side effects:
- Nausea: Zepbound 28% vs Foundayo 25% — slight improvement
- Diarrhea: Zepbound 23% vs Foundayo 18% — improvement
- Injection site reactions: Zepbound 3.2% vs Foundayo 0% — eliminated
During the transition, expect 2-4 weeks of GI adjustment. Your body is adapting to a different receptor activation pattern.
Step-by-Step: How to Make the Switch
Cost Comparison
| Medication | Self-Pay/mo | With Savings Card |
|---|---|---|
| Zepbound 10mg | $1,086/mo | $25/mo |
| Foundayo (maintenance) | $149-349/mo | $25/mo |
| Savings | $787-937/mo saved | $0 difference |
Side Effects Comparison
Calculate Your Personalized Switch Plan
Enter your current medication and dose to get a detailed switching plan with dose mapping, timeline, and cost analysis.
Frequently Asked Questions
Sources & Citations
- SURMOUNT Clinical Trial Program (tirzepatide weight loss data)
- ATTAIN Phase 3 Clinical Trial Program
- Foundayo (orforglipron) FDA Prescribing Information
- Zepbound (tirzepatide) FDA Prescribing Information
- Eli Lilly investor presentations on Foundayo positioning, 2025-2026
Stay Updated
Get notified when Foundayo pricing changes, new GLP-1 options become available, or new switching data is published.Plus personalized updates for your Zepbound → Foundayo switch.
No spam. Unsubscribe anytime. We never share your email.
Ready to Make the Switch?
Talk to a doctor about switching to Foundayo. These telehealth providers offer online consultations and GLP-1 prescriptions.
MedSwitcher may earn a commission from some providers. This does not affect our recommendations. Our switch plans are based on clinical data, not partnerships.